SARAH MANN: Open Payments
NPI 1437161643 · LODI, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 24 payments from 11 companies in 2025. Trend: 2023 $432 · 2024 $483 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Novo Nordisk Inc | 2 | $41 |
| ABBVIE INC. | 2 | $34 |
| PFIZER INC. | 1 | $29 |
| Abbott Laboratories | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
Products named: MOUNJARO, Kerendia, JARDIANCE, LEQVIO, VRAYLAR, PREVNAR 20, ZEPBOUND, FREESTYLE LIBRE 3.
Industry payments across CA — which companies pay providers there.
